Term ends no later than Sep 22, 2028 · Medium confidence
20-year base term ended Dec 5, 2025
In force on USPTO's status record and by its fee record. A terminal disclaimer on file may shorten this term, possibly to a date already past; its reference document is unresolved, so the date above is an upper bound and no earlier date is guessed.
Dec 5, 2005
Sep 22, 2028
May 11, 2010
This patent's term runs 1022 days past its 20-year base term on prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. All three maintenance fees are recorded paid; no more fees are due. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Dec 5, 2005, when this application, 11/295,204, was filed | Dec 5, 2025 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +1022 days, USPTO patent term adjustment record | Sep 22, 2028 | High confidence |
| Terminal disclaimer cap | Disclaimer on file (approved), reference document not resolved | no cap applied, and none guessed | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | no later than Sep 22, 2028 | Medium confidence |
This family
| US 7,713,266 | this patent no later than Sep 2028 | no later than Sep 2028 |
| US 7,850,683 | Term ended no later than Oct 2026 | no later than Oct 2026 |
| US 7,862,558 | Term ended Dec 2025 | Dec 2025 |
| US 7,998,137 | Term ended no later than Dec 2025 | no later than Dec 2025 |
| US 9,072,498 | Term ended Dec 2025 | Dec 2025 |
| US 9,345,526 | Term ended Dec 2025 | Dec 2025 |
| US 10,363,080 | Term ended Dec 2025 | Dec 2025 |
| US 11,963,706 | In force no later than Aug 2029 | no later than Aug 2029 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Feb 13, 2006 Reel 17159, frame 794 | Elkins, Lisa; Williams, Ronald | Echo Healthcare LLC | Assignment of Assignor's Interest |
| Apr 17, 2006 Reel 17483, frame 115 | Echo Healthcare LLC | Myoscience, Inc. | Assignment of Assignor's Interest |
| Dec 19, 2014 Reel 34557, frame 73 | Myoscience, Inc. | Venture Lending & Leasing VII, Inc. | Security Interest |
| Dec 29, 2014 Reel 34713, frame 226 | Myoscience, Inc. | Venture Lending & Leasing VII, Inc. | Corrective Assignment to Correct to Remove Application Number 12160639 Previously Recorded at Reel: 034557 Frame: 0073. Assignor(S) Hereby Confirms the Security Agreement. |
| Feb 4, 2019 Reel 48237, frame 168 | Venture Lending & Leasing VII, Inc. | Myoscience, Inc. | Release of Security Interest |
| Jul 15, 2019 Reel 49758, frame 28 | Myoscience, Inc. | Pacira Cryotech, Inc. | Confirmatory Assignment |
| Dec 14, 2021 Reel 58516, frame 636 | Pacira Cryotech, Inc.; Pacira Pharmaceuticals, Inc.; Flexion Therapeutics, Inc. | Jpmorgan Chase Bank, N.a. | Supplemental Confirmatory Grant of Security Interest in United States Patents |
| Mar 31, 2023 Reel 63213, frame 864 | Jpmorgan Chase Bank, N.a. | Pacira Cryotech, Inc.; Pacira Pharmaceuticals, Inc.; Pacira Therapeutics, Inc. (F/K/A Flexion Therapeutics, Inc.) | Termination and Release of Security Interest in Patents |
| Mar 31, 2023 Reel 63214, frame 108 | Pacira Cryotech, Inc.; Pacira Pharmaceuticals, Inc.; Pacira Therapeutics, Inc. (F/K/A Flexion Therapeutics, Inc.) | Jpmorgan Chase Bank, N.a. | Confirmatory Grant of Security Interest in United States Patents |
| Mar 31, 2023 reel/frame not recorded | Jpmorgan Chase Bank, N.a. | Pacira Cryotech, Inc. | Termination and Release of Security Interest in Patents |
| Mar 31, 2023 reel/frame not recorded | Jpmorgan Chase Bank, N.a. | Pacira Pharmaceuticals, Inc. | Termination and Release of Security Interest in Patents |
| Mar 31, 2023 reel/frame not recorded | Jpmorgan Chase Bank, N.a. | Pacira Therapeutics, Inc. (F/K/A Flexion Therapeutics, Inc.) | Termination and Release of Security Interest in Patents |
| Dec 5, 2025 Reel 73779, frame 532 | Jpmorgan Chase Bank, N.a. | Pacira Cryotech, Inc.; Pacira Pharmaceuticals, Inc.; Pacira Therapeutics, Inc. (F/K/A Flexion Therapeutics, Inc.) | Release of Security Interest |
| Dec 5, 2025 reel/frame not recorded | Jpmorgan Chase Bank, N.a. | Pacira Cryotech, Inc. | Release of Security Interest |
| Dec 5, 2025 reel/frame not recorded | Jpmorgan Chase Bank, N.a. | Pacira Pharmaceuticals, Inc. | Release of Security Interest |
| Dec 5, 2025 reel/frame not recorded | Jpmorgan Chase Bank, N.a. | Pacira Therapeutics, Inc. (F/K/A Flexion Therapeutics, Inc.) | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer is on file (approved) and its reference document is not resolved. A disclaimer would cap the term earlier than Sep 22, 2028. We will not guess the cap.